Research Documents

Abstract submissions are invited for the 2017 HepHIV Conference in Malta.

Aims and eligibility
HepHIV abstracts should contain original material from recent work that is not yet in publication. The HepHIV conference encourages research on testing and linkage to care as well as best practice examples and lessons learned. Also abstracts on testing and linkage to care of key populations within the fields of viral hepatitis and HIV are encouraged.

Abstract deadline: 17 October 2016
Abstract decisions will be communicated to authors in November 2016.

To submit an abstract and please click here .
Abstract mentoring programme

HepHIV has implemented an abstract mentoring programme, an extra support for those less familiar with submitting scientific abstracts but with great best practice examples. The goal of the progamme is to help authors present their material clearly and concisely before their abstracts are submitted for the formal abstract review process. Authors wishing to participate in the abstract mentoring programme are asked to send their draft abstract (in MS Word format) to projects@eatg.org by the 3 October 2016. Please indicate also to which abstract category (1-11, see below) you wish to submit your abstract.
Abstract categories
Please see below list of topics/ tracks available for submitted abstracts for HepHIV 2017:

1) Combined HIV, STI and viral hepatitis testing
2) New testing technologies to increase testing coverage, e.g. home based HIV and/or viral hepatitis testing/sampling
3) Education and training of staff to perform HIV and/or viral hepatitis testing
4) Tracking technologies and partner notifications for HIV and/or viral hepatitis
5) Monitoring and evaluation of HIV and/or viral hepatitis testing
6) Cost-effectiveness of HIV and/or viral hepatitis testing strategies
7) Missed opportunities for HIV and/or viral hepatitis testing
8) Continuum of care for HIV and/or viral hepatitis
9) Stigma and legal and regulatory barriers for HIV and hepatitis testing
10) Late presentation
11) Increasing importance of testing for harm reduction services